clinicopathological conference |
|
Indian Pediatr 2019;56: 868-872 |
|
Severe Pulmonary Arteriopathy in a Neonate
with Congenital Rubella Syndrome and Patent Ductus Arteriosus
|
Supreet Khurana 1,
Akriti Bansal2,
Shiv Sajan Saini1,
Anand Mishra3 and
Praveen Kumar1
From 1Division of Neonatology,
Department of Pediatrics; 2Department of Pathology;
and 3Department of Cardiothoracic Vascular Surgery;
Post Graduate Institute of Medical Education and Research, Chandigarh,
India.
Correspondence to: Dr Shiv Sajan Saini, Assistant
Professor, Division of Neonatology, Department of Pediatrics, Post
Graduate Institute of Medical Education and Research, Chandigarh, India.
[email protected]
|
Neonates with congenital rubella
syndrome (CRS) are known to have associated congenital cardiac
malformations. Patent ductus arteriosus (PDA) is one the most common
cardiac anomalies associated with CRS. PDA refractory to medical
management and associated with ventilatory dependence is considered for
surgical ligation. However, the management of PDA can be challenging in
the presence of underlying lung disease or pulmonary vascular disease.
Outcomes after closure in neonates are dependent upon age, weight,
nutritional status, pre-operative pulmonary arterial hypertension and
presence of chronic lung disease. We present a neonate with CRS who
required surgical PDA closure. The neonate developed severe pulmonary
arterial hypertension which led to fatal outcome. The clinical course is
corroborated with histo-pathological changes observed on the autopsy of
this neonate.
Keywords: Complications, Epidemiology, German
measles, Pregnancy.
|
Clinical Protocol
History and examination: A male neonate was born
at 35 weeks gestation with a birth weight of 1016g to a primigravida
mother with the antenatal history of oligohydramnios and intra-uterine
growth retardation (IUGR). The baby was delivered by induced vaginal
delivery secondary to meconium stained amniotic fluid. His APGAR scores
were 6 and 8 at 1 and 5 minutes after birth. His physical examination
revealed symmetrical (IUGR) [head circumference 25 cm (4.5 z-score),
Ponderal index= 2], bilateral cataract and hepatosplenomegaly.
Investigations: His complete hemogram revealed
thrombocytopenia; cranial ultrasonography (USG) was suggestive of
increased echogenicity in bilateral basal ganglia and periventricular
region, and USG abdomen was normal. Two-dimensional echocardiography
(2D-ECHO) was suggestive of atrial septal defect (ASD) and 4 mm patent
ductus arteriosus (PDA) with left to right shunt. Toxoplasma, rubella,
cytomegalovirus (CMV) and herpes (TORCH) work-up revealed positive
Rubella Immunoglobulin M (IgM). His renal and liver function tests were
normal. His acute phase reactants were negative and blood/ cerebrospinal
fluid (CSF) cultures were sterile.
Course and management: The baby was managed as a
case of congenital rubella syndrome. He developed tachypnea after birth
requiring oxygen delivered via nasal prongs oxygen for initial 2
days. His enteral feeds were slowly hiked and he reached full enteral
feeds on 6 th day. He again
developed respiratory distress on day 11 requiring re-initiation of head
box oxygen. His chest radiograph revealed inhomogeneous infiltrates.
Antibiotics were initiated and were stopped after 5 days as his septic
workup was negative and his blood cultures were sterile. However, he
continued to require oxygen by nasal prongs. On day 18, he developed
clinical signs of congestive heart failure (CCF) requiring invasive
ventilation, fluid restriction, and intravenous furosemide. He also
received red blood cell transfusion as he had high inspired oxygen
requirement. His chest X-ray was suggestive of consolidation and
intravenous antibiotics were restarted. High frequency ventilation was
started in view of worsening respiratory distress. His respiratory
status improved and he was shifted to synchronized intermittent
mandatory ventilation (SIMV). His blood and CSF cultures were
unremarkable and antibiotics were stopped after 7 days. Within the next
48 hours, the CCF worsened requiring initiation of dobutamine infusion
and digoxin. Digoxin was later withheld as he developed signs of digoxin
toxicity. As his CCF was resistant to medical management, PDA ligation
was planned.
Pre-operative echocardiography showed large PDA with
moderate pulmonary arterial hypertension (PAH); pulmonary arterial
pressures were 45 mm Hg with Qp:Qs (Pulmonary : Systemic blood flow) =
2:1. On day 48 of life, he underwent bed-side PDA closure surgery in the
NICU, during which 5 mm PDA was closed with a titanium clip. The aortic
arch was intact. Chest was closed with left pleural drain in-situ.
After 2 hours, his ventilatory requirement increased. Echocardiography
revealed closed PDA, moderate to severe PAH with poor cardiac
contractility (ejection fraction 30%). The baby was initiated on
dobutamine and milrinone infusions as inhaled nitric oxide was
unavailable at that time. However, pulmonary pressures did not improve
requiring initiation of sildenafil. Nevertheless, the baby gradually
developed respiratory failure, refractory shock and expired on day 58 of
life. His blood cultures obtained before death were sterile.
Clinical analysis: In view of clinical
findings and examination–preterm symmetric IUGR neonate, microcephaly,
cataract, PDA–along with laboratory investigations showing
thrombocytopenia and rubella IgM sero-positivity, diagnosis of
laboratory confirmed congenital rubella syndrome (CRS) was made
in accordance with WHO CRS Surveillance standards
[1]. The neonate had CCF, which was refractory to medical management. He
also had underlying BPD contributed by prematurity, PDA, intercurrent
infections and chronic ventilator dependence. The underlying reason for
his postoperative deterioration was refractory CCF and PAH. Other
possible differentials included healthcare associated bacterial
infections (HAI), and acquired CMV infection. HAI were ruled out by
blood cultures and sepsis workup. Acquired CMV (through blood
transfusions or perinatally acquired) was ruled out by DNA PCR as well
as negative serology. The sensitivity and specificity of reverse
transcriptase polymerase chain reaction as per literature varies between
83-95% and 95-100% respectively [2].
The reason for deterioration in the post-operative
period seemed to be pulmonary arterial hypertension. It was secondary to
either broncho-pulmonary dysplasia (BPD) or/and worsening due to surgery
induced inflammation [3]. It is evident from the literature that a
long-standing large sized PDA can damage pulmonary parenchyma and cause
re-modeling of pulmonary vasculature, which possibly happened in our
case [4]. Preoperative hemodynamic information does not correlate
well with post-operative outcome for various reasons [4].
Open-house Discussion
Treating unit senior resident: The case was
challenging in terms of managing ventilation and medically refractory
CCF which in presence of a large PDA required surgical closure of PDA.
But on the hindsight closure actually worsened the preexistent pulmonary
hypertension. In the autopsy of lungs, we expect findings concomitant
with bronchopulmonary dysplasia and distortion of normal lung
architecture in form of alveolar simplification, smooth muscular
hyperplasia, peribronchiolar and interstitial fibrosis, areas of
atelectasis and abnormal microvasculature. Also we have suspicion of CMV
pneumonitis. The findings of CNS will be important due to USG head
abnormalities in neonate. Whether some of findings in heart are missed
will also be informative.
Cardiologist: Post PDA ligation syndrome is
unlikely to lead to worse outcome in this neonate as it was well managed
and cardiac functions improved echo-cardiographically after starting
dobutamine. Pulmonary hypertension crisis is known in cases with only
severe pulmonary vasoconstrictive disease and is less likely to be a
cause of mortality as in an unpublished study of 500 neonates with
moderate to large PDA, wherein cardiac functions improved after PDA
ligation, mortality was decreased post operatively.
Treating unit consultant: Post PDA ligation
syndrome does not seem to be a contributor of mortality in our neonate.
We expect BPD changes in lungs that seem to be contributed by multiple
intercurrent illnesses and by a large PDA. Also we failed to identify
any infectious illness by means of cultures. Although we tried to
exclude congenital CMV by means of investigations, but perinatally
acquired CMV remains a possibility.
Pediatrician 1: Congenital Rubella syndrome can
have findings of bilateral basal ganglia calcifications, peri-ventricular
leucoencephalopathy and temporal cysts on brain.
Pediatrician 2: Chest x-rays were suggestive of
hyperinflation in the patient, which due to increased lung volumes can
worsen pulmonary hypertension.
Treating unit senior resident: Our patient was
judiciously managed with high frequency ventilation and required high
MAP and fraction of inspired oxygen (FiO 2).
We could not decrease the ventilatory pressures as there was severe
parenchymal disease with co-existing PAH.
Pathology Protocol
A complete autopsy was performed. Weight of neonate
was 1438 gm, crown heel length was 40 cm and occipitofrontal
circumference (OFC) were 27 cm, All these parameters were below -2
z-score for age. There was 10 mL serous fluid in pericardial cavity. The
weight of heart was 20 g with globular shape and blunt apex and situs
solitus. The pulmonary trunk was grossly dilated. PDA was clipped and an
ASD measuring 5 mm was identified. Right ventricular wall was
hypertrophic and measured 5 mm (normal values 1.3-4 mm) [5]. Microscopy
of the right ventricle revealed mild anisonucleosis of the cardiac
muscles indicating right ventricular hypertrophy.
Both lungs weighed together 90 and were overweight.
The pleurae were dull and fibrins tags were noted on lungs suggestive of
pleuritis. Both the lungs showed areas of consolidation and hemorrhage.
Microscopy showed areas of intra-alveolar hemorrhage and interstitial
widening with no evidence of fibrosis. Interstitial widening was
predominantly caused by pulmonary capillary proliferation. In addition,
there was abundance of type 2 pneumocytes in alveoli. Reticulin stain
demonstrated interstitial widening with pulmonary capillary
proliferation. There was evidence of pulmonary arterial hypertension in
the form of pulmonary arteriopathy. The pre-acinar and intra-acinar
pulmonary arteries showed intimal hyperplasia with medial hypertrophy
and adventitial thickening. A few arteries had complete occlusion of
lumen due to intimal proliferation. These changes were better
appreciated on elastic von- Gieson stain (Web Fig. 1).
There was an area of consolidation with neutrophilic inflammatory
infiltrate in bronchial lumen and surrounding alveoli confirming
bronchopneumonia (Fig. 2). Stains for gram positive, gram
negative bacteria and PAS stains for fungus were negative. No CMV
inclusions were found.
Brain weighed 320 g and OFC was 27 cm suggestive of
microcephaly. There was softening of white matter and focal
calcifications in the white matter, periventricular and basal ganglia
region (Web Fig. 2). Micronodules were appreciated in
white matter and basal ganglia. Edema and pallor was found in
periventricular area consistent with periventricular leucomalacia (Web
Fig. 3).
Liver, spleen, kidney, urinary systems, esophagus,
stomach. thymus, bone marrow, lymph nodes, adrenal and testes were
normal.
Final autopsy diagnosis:
A 2-month old male with evidence of congenital
rubella syndrome and surgically clipped PDA:
• Pulmonary artery hypertension - Pulmonary
arteriopathy grade 3, pulmonary micro vasculopathy
• Bronchopneumonia
• Congenital heart disease- ASD, PDA
• Microcephaly, periventricular leukomalacia,
calcifications in brain
Open-house Discussion
Pediatrician 3: Congenital rubella syndrome
surveillance is being conducted in 5 centers since 2016 (Postgraduate
Institute of Medical Education and Research, Chandigarh; All India
Institute of Medical Sciences, Jodhpur; KEM Hospital,Pune; Indira Gandhi
Institute for Child Health, Bengaluru; Christian Medical College,
Vellore). In a period of 8 months, during December 2016-July 2017; 207
cases of CRS were identified as clinical cases with 72 laboratory
confirmed cases (35% positivity rate). Among laboratory confirmed cases
of CRS, 83% had congenital heart diseases, 62% had eye manifestations
and 35% had hearing deficits on 1-year follow up. Most common associated
condition is congenital heart disease, though cataract had been most
common defect leading to suspicion of CRS. Sixty percent mothers, whose
neonates developed CRS, were <26 years at age of conception [6].
Treating unit consultant: Pathological findings
were quite interesting. As opposed to our expectations of significant
fibrotic changes in lungs affected with BPD, there were predominant
angio-dysplastic changes. At 35 weeks of gestation, as lungs are in
saccular phase of development, exposure to risk factors leading to
chronic lung disease (CLD) can predispose to development of capillary
proliferation rather than fibrosis. Findings of calcifications in
central nervous system were also of interest as toxoplasma and CMV are
common congenital infections known to cause these findings rather than
CRS.
Discussion
The burden of congenital rubella in developing
nations is much higher than developed countries, where annual incidence
of congenital rubella is less than one per hundred thousand live births
[7]. As per the latest WHO update, there has been a constant increase in
number of cases of CRS over the last decade [8]. An infant with CRS can
present with one or more of the following clinical features – cataract,
congenital glaucoma, congenital heart disease (PDA or peripheral
pulmonary stenosis), hearing impairment, hepatosplenomegaly,
microcephaly, meningoencephalitis, radiolucent bone disease etc [9]. The
clinical presentation of neonates with CRS depend on the gestational age
of fetus at the time of maternal infection. Structural heart defects and
eye abnormalities occur if maternal infection is acquired before eight
weeks; while hearing defects are more common, if infections occurs till
18 weeks of pregnancy [10]. Maternal infection later in course of
pregnancy might manifest with only intrauterine fetal growth
restriction. The index neonate manifested with several clinical features
suggestive of CRS and the diagnosis was also confirmed with presence of
rubella specific IgM antibodies. In addition to the several common
features of CRS, the index neonate also had calcifications in white
matter, periventricular area and basal ganglia [11]. The most common
finding in CRS patients is that of microcephaly as in our case and most
consistent pathological findings are that of vascular destruction [12].
Intracranial calcifications are more frequently associated with
congenital CMV and toxoplasmosis but are rarely reported in CRS [13].
There is no definitive management of CRS. The
treatment is primarily symptomatic, based on organ system involvement
[14]. Due to multiple organ involvement, a multidisciplinary team
involvement is warranted [15]. The management of PDA was tricky in our
case. PDA closure was warranted as the PDA size was big, CCF was not
fully controlled with medical therapy and ventilator dependence [16].
However presence of concomitant pulmonary arterial hypertension and
underlying BPD posed significant challenge for deciding surgical
closure. Although PDA closure is contraindicated in severe pulmonary
artery disease, it can be considered in the presence of reversible
pulmonary disease [17]. PDA closure in neonates with PAH is recommended
in cases with lower baseline pulmonary vascular resistance along with
lower pulmonary arterial pressures, Qp:Qs ratio of >1.5, and a pulmonary
arterial to systemic arterial pressure ratio <0.5 [18,19]. In this case,
Qp: Qs ratio was 2:1 and pulmonary arterial pressure was 45 mm Hg
(moderately elevated) prior to PDA ligation. Thus, after excluding
irreversible pulmonary vascular disease, the surgical ligation was
decided in multidisciplinary meeting.
The baby had persistent ventilator requirement after
PDA closure, which worsened and eventually baby died of respiratory
failure. BPD development is associated with the altered pro-inflammatory
cytokines/chemokines profile as well as mediators of parenchymal and
vascular remodeling. Waleh and colleagues reported that the surgical PDA
closure led to increase in the expression of pro-inflammatory mediators
(COX-2, TNF-alpha, and cells expressing CD14), and decreased expression
of angiogenesis genes (angiopoietin-2 and TGF beta 3) [20].
Additionally, surgical PDA ligation decreased pulmonary alpha-ENaC
containing channels expression, which is involved in trans-epithelial
sodium transport related to clearance of alveolar fluid. Furthermore,
these changes were observed in lung tissue taken from the side opposite
to the ligation even after one week of surgery. Thus, in our case
possibly the surgical ligation has escalated the underlying
pro-inflammatory state which was already present due to BPD. The autopsy
findings are also suggestive of the same. The histopathology of baby’s
lung showed the areas of consolidation with neutrophilic inflammatory
infiltrate without any evidence of bacteria, fungus or CMV. These
findings clearly point towards a non-infectious pro-inflammatory state.
It is also noteworthy that ante-mortem sepsis workup was negative.
Similar observations have previously been reported by other authors
[21]. These findings have clear implications in the clinical practice.
The physicians should be aware of this phenomenon. All possible efforts
should be done to provide gentler ventilation, improved nutrition to
counter pro-inflammatory states in such setting. There is definite role
of multidisciplinary meetings including neonatology, cardiology and
cardiothoracic surgery to take decision in case to case basis
considering physiology of these neonates. Further research is needed to
optimize the timings of surgical ligation in such complex settings.
Acknowledgements: Prof Ashim Das for
conducting autopsy, providing us with essential information regarding
histopathological findings and modification and approval of pathology
protocol.
Contributors: SK: clinical management of
patient, preparation of initial draft of manuscript, AB: assisted in
performing the autopsy, presentation of pathology protocol in CPC,
provision and description of histo-pathological image findings; SSS:
clinical management of patient, critically reviewed the manuscript for
its contents, modification and approval of manuscript; AM: surgical
management of patient and approval of manuscript; PM: clinical
management of patient, modification and approval of manuscript.
Discussants: Clinical discussant pediatrician:
Akhil Raj MS, Treating unit senior resident: Supreet Khurana;
Cardiologist: Ashish Tiwari; Treating unit consultant: Shiv
Sajan Saini; Pediatrician 1: Sumeet Dhawan; Pediatrician
2: Suresh Kumar Angurana; Pediatrician 3: Sanjay Verma,
Clinical discussant pathologist: Akriti Bansal.
Funding: None; Competing interest:
None stated.
References
1. World Health Organization ;WHO
2014.WHO-recommended Surveillance Standard of Rubella and Congenital
Rubella Syndrome: Available from
http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/rubella_standards/en.
Accessed December 11, 2017.
2. Mace M, Cointe D, Six Caroline, Levy-Bruhl D,
Chatelet IP, Ingrand D, et al. Diagnostic value of Reverse
Transcription- PCR of amniotic fluid for prenatal diagnosis of
congenital rubella infection in pregnant women with confirmed primary
rubella infection. J Clin Microbiol. 2004;42:4818-20.
3. Niu MC, Mallory GB, Justino H, Ruiz FE, Petit CJ.
Treatment of severe pulmonary hypertension in the setting of the large
patent ductus arteriosus. Pediatrics. 2013;131:e1643-49.
4. Bhalgat PS, Pinto R, Dalvi VB. Transcatheter
closure of large patent ductus arteriosus with severe pulmonary arterial
hypertension: Short and intermediate term results. Ann Pediatr Cardiol.
2012;5:135-40.
5. Guzeltas A, Eroglu GA. Reference values for
echocardiographic measurements of healthy newborns. Cardiol Young.
2012;22:152-7.
6. Murhekar M, Bavdekar A, Benakappa A, Santhanam S,
Singh K, Verma S, et al. Sentinel surveillance for congenital
rubella syndrome- India, 2016-17. MMWMR Morb Mortal Wkly Rep.
2018;67:1012-6.
7. Singh MM. Need for rubella vaccination in India.
BMJ .2014;349:g4844.
8. World Health Organization. WHO 2018. Global and
Regional Immunization Profile South-East Asia Region. Available from:
http://www.who.int/immunization/ monitoring_surveillance/data/gs_searprofile.pdf.
Accessed November 3, 2018.
9. Lanzieri T, Redd S, Abernathy E, Icenogle J.
Congenital Rubella Syndrome. Centers for Disease Control and Prevention
2018. Available from:
https://www.cdc.gov/vaccines/pubs/surv-manual/chpt15-crs.html.
Accessed December 12, 2018
10. Dobson RS, Edwards SM, Weisman LE, Armsby C.
Uptodate 2018. Congenital Rubella Syndrome: Clinical Features and
Diagnosis. Available from:
https://www.uptodate.com/contents/congenital-rubella-syndrome-clinical-features-and-diagnosis.
Accessed December 12, 2018.
11. Rao JN, Chancham S, Reddy UN, Nagasravani J,
Mazher N, Mustafa ST. Congenital rubella syndrome with basal ganglia
calcification and bilateral nuclear cataracts in a neonate: A rare
entity. Sch J Med Case Rep. 2014;2:470-2.
12. Eckstein M, Vijayalakshmi P, Killedar M, Gilbert
C, Foster A. Etiology of childhood cataract in south India. Br J
Ophthalmol. 1996;80:628-32.
13. Numazaki K, Fujikawa T. Intracranial
Calcifications with congenital rubella syndrome in a mother with
serological immunity. J Child Neurol. 2003;18:296-7.
14. Cherry JD, Adachi K. Rubella virus. In:
Cherry JD, Harrison GJ, Kaplan SL, editors. Feigin and Cherry’s Textbook
of Pediatric Infectious Diseases, 7th ed, Philadelphia: Elsevier
Saunders, 2014. P. 2195.
15. Plotkin SA, Reef SE, Cooper L S Alford CA.
Rubella. In: Remington, JS, Klein, JO, Wilson, CB, editors,
Infectious Diseases of the Fetus and Newborn Infant, 7th ed,
Philadelphia: Elsevier Saunders, 2011. P. 861.
16. Warnes CA, Williams RG, Bashore TM, Child JS,
Connolly HM, et al. Management of patent ductus arteriosus.
Circulation. 2008;118:e714.
17. Rigby ML. Closure of a large patent ductus
arteriosus in adults: first do no harm. Heart. 2007;93:417.
18. Zhang DZ, Zhu XY, Lv B, Cui CS, Han XM, Sheng XT,
et al. Trial occlusion to assess the risk of persistent pulmonary
arterial hypertension after closure of a large patent ductus arteriosus
in adolescents and adults with elevated pulmonary artery pressure. Circ
Cardiovasc Interv. 2014;7:473-81.
19. Yan C, Zhao S, Jiang S, Xu Z, Huang L, Zheng H,
et al. Transcatheter closure of patent ductus arteriosus with
severe pulmonary arterial hypertension in adults. Heart. 2007;93:514-8.
20. Waleh N, Mccurnin CD, Yoder AB, Shaul PW, Clyman
RI. Patent ductus arteriosus ligation alters pulmonary gene expression
in preterm baboons. Pediatr Res. 2011;69:212-6.
21. Niu MC, Mallory GB, Justino H, Ruiz FE, Petit CJ. Treatment of
severe pulmonary hypertension in the setting of the large patent ductus
arteriosus. Pediatrics 2013;131:e1643-49.
|
|
|
|